Please login to the form below
Illumina
This page shows the latest Illumina news and features for those working in and with pharma, biotech and healthcare.
Loxo, Bayer get quick FDA review for ‘precision’ cancer drug
To try to address that issue, Loxo formed a partnership earlier this year with Illumina to develop a companion diagnostic – called TruSight Tumour 170 – that will use sequencing to identify whether
Latest news
-
Daily Brief: Calls for early Brexit deal for science and innovation, Gottlieb threatens to name and shame
Genomics. Illumina buys genome data analysis firm. Genome sequencing leader Illumina has paid $100m for Edico Genome, a company which has developed software to speed-up the reading of genetic data. ... President of Product Development at Illumina.
-
Roche buys gene sequencing firm
Illumina to the altar. ... which is predicted to swell to $8.7bn by 2020 but at the moment is still dominated by Illumina with around 75% market share,.
-
AstraZeneca joins Genomics England consortium
AstraZeneca joins Genomics England consortium. Combines with other pharma firms such as Illumina to utilise genetic data to create new medicines. ... It joins another of other firms, including Biogen and Illumina, who have signed up to the project.
-
NHS set to deliver 'world-leading' genomics centres
After samples are collected, they will be sent securely to its gene sequencing partner Illumina - results will be returned to the NHS for validation and clinical action.
-
AZ advances immuno-oncology ambitions
Buys imaging company and signs PD-1 collaborations with Pharmacyclics and J&J
More from news
Approximately 6 fully matching, plus 20 partially matching documents found.
Latest Intelligence
-
Deal Watch January 2017
IBM Watson Health/ Illumina. Partnership to integrate Watson for Genomics into Illumina's BaseSpace Sequence Hub and tumour sequencing process to expand access to genomic data.
-
Digital: Fallacy or the Future Face of Pharma Marketing?
Speakers. Dan Coffin, Global Head of Illuminas Health. Dan now heads up the global pharmaceutical arm of Illuminas and brings an interesting mix of experiences having worked agency side at Isis
-
Digital: Fallacy or the Future Face of Pharma Marketing?
Speakers. Dan Coffin, Global Head of Illuminas Health. Dan now heads up the global pharmaceutical arm of Illuminas and brings an interesting mix of experiences having worked agency side at Isis
-
Pharma deals during July 2013
Roche, rumoured to be interested in Alexion, may still be smarting from the battle to try and take over Illumina last year.
-
What can pharma learn from Olympic sports coverage?
So where could Roche go next? With its unsuccessful takeover bid for Illumina, it could be a move into genetic sequencing to augment their oncology capability and more besides.
More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.
Latest appointments
-
Illumina expands board of directors
Illumina expands board of directors. John Thompson brings experience from IBM and Microsoft. ... San Diego, US-based Illumina has appointed John Thompson to its board of directors.
-
GlobalData makes Americas appointment
He has spent 18 years in varous positions in the life sciences consulting industry, including roles at, Bionest Partners, IMS Management Consulting, and Illumina Inc.
More from appointments
Approximately 1 fully matching, plus 1 partially matching documents found.
Latest from PMHub
-
Why is the UK lagging behind the rest of Europe in cancer survival?
To bring home the importance of this diagnostic technology, the CEO of Illumina (a top DNA sequencing firm) believes this technology will become the “ stethoscope for the next 200 years.” A
-
Dan Coffin joins London Headquarters as Director
Most recently, Dan was employed at Illuminas where he established and ran their healthcare market research arm.
-
Dan Coffin joins London Headquarters as Director
Most recently, Dan was employed at Illuminas where he established and ran their healthcare market research arm.
More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.
Featured jobs
-
Senior Training Manager - Surrey
-
Competitive Salary &Bonus
- Senior Writer, Healthcare Advertising, London
-
Excellent package
- Head of Market Access - International - Based Cambridge
-
Excellent Basic, Bonus and Flex Benefits
-
Senior Medical Writer
-
Salary is DOE
- Account Director, Healthcare Communications Agency
-
£54, 000- £60, 000
- Senior Medical Writer, Principal Medical Writer, Scientific Dire...
-
£40000 - £75000 Bonus Benefits
- Principal Medical Writer / Editorial Director – Medical Communic...
-
£60, 000 - £80, 000
- Integrated Brand/ Digital Senior Account Director, London
-
Excellent package
-
Healthcare PR Senior Account Manager
-
Salary TBC
- Technical Manager – Developer and Commercial Excellence, Healthc...
-
Excellent package
-
Associate Scientific Director
-
Salary TBC
-
Systematic Review Lead- London
-
Negotiable
- Science Writer, Healthcare Advertising Agency
-
£40, 000 - 45, 000 DOE benefits,
- Scientific Director – Medical Communications - New York or Remot...
-
$100000 - $150000
- Senior Strategist/ Planner, Healthcare Marketing, London
-
Excellent package
-
Account Manager
-
Negotiable
Subscribe to our email news alerts
PMHub
bmore group
OUR PROMISE: BETTER HEALTH FROM TRIAL TO TREATMENT.We are a full service, independent network of specialist agencies under one roof....
Latest intelligence
- The gene therapy revolution
- Gene therapies are bringing new hope for many people with diseases caused by genetic disorders...
- PM Society Digital Awards – the power of together
- Our chief executive, Emma Statham, writes about the value of awards and the power of together....
- Seduce anyone in four simple steps
- You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
Quick links
Infographics
